PRODRUGS FOR DERMAL DELIVERY

被引：35

作者：

CHAN, SY ^{[1
]}

PO, ALW ^{[1
]}

机构：

[1] QUEENS UNIV BELFAST, SCH PHARM, DRUG DELIVERY RES GRP, 97 LISBURN RD, BELFAST BT9 7BL, ANTRIM, NORTH IRELAND

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1989年 / 55卷 / 01期

关键词：

D O I：

10.1016/0378-5173(89)90270-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 16

页数：16

共 59 条

[1] SKIN AS AN ACTIVE METABOLIZING BARRIER .1. THEORETICAL-ANALYSIS OF TOPICAL BIOAVAILABILITY [J].

ANDO, HY ;

HO, NFH ;

HIGUCHI, WI .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (11) :1525-1528

[2]

BICKERS DR, 1980, EXTRAHEPATIC METABOL, P295

[3] IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .7. DERMAL DELIVERY OF CROMOGLYCIC ACID (CROMOLYN) VIA ITS PRODRUGS [J].

BODOR, N ;

ZUPAN, J ;

SELK, S .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1980, 7 (01) :63-75

[4] SOFT DRUGS .4. 3-SPIROTHIAZOLIDINES OF HYDROCORTISONE AND ITS DERIVATIVES [J].

BODOR, N ;

SLOAN, KB ;

LITTLE, RJ ;

SELK, SH ;

CALDWELL, L .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 10 (04) :307-321

[5] SKIN STRUCTURE AND METABOLISM - RELEVANCE TO THE DESIGN OF CUTANEOUS THERAPEUTICS [J].

BUCKS, DAW .

PHARMACEUTICAL RESEARCH, 1984, (04) :148-153

[6] LEACHING OF HYDROLYTIC ENZYMES FROM HUMAN-SKIN IN CUTANEOUS PERMEATION STUDIES AS DETERMINED WITH METRONIDAZOLE AND 5-FLUOROURACIL PRO-DRUGS [J].

BUNDGAARD, H ;

HOELGAARD, A ;

MOLLGAARD, B .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (03) :285-292

[7]

BUNDGAARD H, 1985, DESIGN PRODRUGS, P1

[8]

BUNDGAARD H, 1988, Patent No. 615

[9] RESISTANCE TO ENZYMATIC-HYDROLYSIS AS A PARAMETER IN DRUG POTENCY [J].

CHEUNG, YW ;

PO, ALW ;

IRWIN, WJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (2-3) :325-333

[10] CUTANEOUS BIOTRANSFORMATION AS A PARAMETER IN THE MODULATION OF THE ACTIVITY OF TOPICAL CORTICOSTEROIDS [J].

CHEUNG, YW ;

PO, ALW ;

IRWIN, WJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 26 (1-2) :175-189

← 1 2 3 4 5 6 →